Actively Recruiting

Age: 18Years +
All Genders
NCT04696081

Atrial Fibrillation in Active Cancer Patients

Led by University Hospital, Caen · Updated on 2024-08-09

1000

Participants Needed

1

Research Sites

226 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Caen

Lead Sponsor

U

University Hospital, Marseille, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III oncological trials and cardiological guidelines. The objective of this study is to create a prospective multicenter international registry of adult patients with an active cancer and experiencing atrial fibrillation to study major cardiovascular events occurrence during a 1 year follow-up.

CONDITIONS

Official Title

Atrial Fibrillation in Active Cancer Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients
  • Outpatients or hospitalized patients
  • Confirmed cancer excluding basal-cell or squamous-cell carcinoma of the skin, primary brain tumor, known intracerebral metastases, or acute leukemia
  • Active cancer defined as diagnosed within past 6 months or recurrent locally advanced or metastatic cancer
  • Receiving anticancer treatment at enrollment or within 6 months before enrollment
  • At least one episode of atrial fibrillation (new onset after cancer diagnosis or recurrence after cancer diagnosis)
  • In sinus rhythm at time of cancer diagnosis
Not Eligible

You will not qualify if you...

  • Patients receiving palliative care or with conditions leading to expected death within one month after atrial fibrillation occurrence
  • History of long-standing persistent or permanent atrial fibrillation prior to cancer diagnosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Alexandre

Caen, Normandy, France, 14000

Actively Recruiting

Loading map...

Research Team

J

Joachim Alexandre, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here